热门资讯> 正文

Nasus Pharma首席财务官Eyal Rubin将离职

2026-08-19 19:05

Nasus Pharma(NSRX) 0
360数科(QFIN) 0

Nasus Pharma (NSRX) on Wednesday said Chief Financial Officer, Eyal Rubin will be leaving the company to pursue a new opportunity outside the life science industry.
Rubin will remain with Nasus through September 18, 2026, and will work closely with the company to ensure a seamless and orderly transition.
Oren Elmaliach, the company’s Director of Finance, has been appointed interim CFO.
Press release

More on Nasus Pharma Ltd.

Seeking Alpha’s Quant Rating on Nasus Pharma Ltd.
Historical earnings data for Nasus Pharma Ltd.
Financial information for Nasus Pharma Ltd.

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。